A new antibiotic, structurally related to cephaloglycin, has been assigned the generic name cephalexin, 7-(D-ca-amino-a-phenylacetamido)-3-methyl-3-cephem-5-carboxylic acid. In vitro antimicrobial activity of cephalexin does not equal that of cephaloglycin. However, excellent oral absorption and lack of serum binding of cephalexin compensates significantly for the lower in vitro activity. Exceptional efficacy against experimental bacterial infections in mice was obtained with cephalexin therapy as compared with cephaloglycin, tetracycline, and chloramphenicol. The data suggest that cephalexin merits clinical trial.
Cephalexin, 7-(D-a-amino -a-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid, is structurally related to cephaloglycin. This antibiotic is a white crystalline compound soluble at approximately 2 mg/ml in distilled water at 25 C. Structures for cephalexin and cephaloglycin are compared in Fig. 1 Effect ofhuman sera on antibacterial activity. Serum and buffer standard curves, from assays described above, were compared to estimate the percentage of antibacterial activity bound by human sera. Mouse blood and urine levels. The previously described disc-plate assay was utilized to compare the blood and urine levels of cephalexin, cephaloglycin, and penicillin V, after oral administration of 20 mg of the antibiotics per kg. Blood was obtained from the orbital sinus with heparinized hematocrit tubes, and assayed immediately (2). Urine samples were diluted and assayed as they were collected.
Experimental infections. Groups of white mice (McAllister strain, 11 to 13 g) were treated orally at 1 and 5 hr after intraperitoneal bacterial challenge, and were observed for 7 days.
RESULTS AND DISCUSSION
The susceptibilities of a number of gram-negative organisms to 30-,ug discs of cephalexin, Table 4 . stability at 37 C, tube dilution mim concentration (MIC) end points could be read after the usual overni It is evident from the data presei that cephalexin exhibits bacteri After 24 hr of incubation of tube dilution tests for alexin these representative bacteria, viable-cell counts aiogiycin showed that MIC values were usually the bacillin tericidal levels. Standard curves obtained with S. lutea, by use of 6-mm discs saturated with solutions of cephalexin, in either human serum or pH 7.0 buffer were identical. Lack of difference in the two curves indicated no loss of antimicrobial activity of cephalexin in human serum. Under identical conditions, a 24% reduction of cephaloglycin activity was demonstrated.
Excellent oral absorption of cephalexin is evident from the mouse blood-level studies sum-9 , 0 marized in Fig. 2 . Blood levels of cephalexin 90 120 exceeded those obtained with similar doses of cephaloglycin and penicillin V. Urine concentraalexin, cephalo-tions of cephalexin, which were in excess of 2,500 inlistration of 20 .g/ml at 60, 90, and 120 min after oral age of four mice. administration, provided additional evidence for good oral absorption. of other culture Activities of cephalexin, cephaloglycin, tetracycline, and chloramphenicol in the test tube and lexin at three in experimental bacterial infections in mice are Because of the compared in Table 6 . The amounts of cephalexin imal inhibitory required for inhibition of the bacteria in vitro for cephalexin were higher than those for other antibiotics ight incubation. examined. However, the ED50 values obtained for nted in Table 5 cephalexin were equal to or lower than the values icidal activity. found for the other antibacterial agents evaluated. This difference between in vitro and in vivo activity is probably attributable to the excellent oral absorption (Fig. 2) 
